EDGAR Filing Documents for 0001437749-21-017701

Form 8-K - Current report:

SEC Accession No. 0001437749-21-017701

Filing Date

2021-07-28

Accepted

2021-07-28 08:30:21

Documents

Period of Report

2021-07-27

Items

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	cbli20210706_8k.htm	8-K	73647
2	EXHIBIT 3.1	ex_263564.htm	EX-3.1	6477
3	EXHIBIT 10.1	ex_261884.htm	EX-10.1	164354
4	EXHIBIT 10.2	ex_261885.htm	EX-10.2	8983
5	EXHIBIT 10.3	ex_263536.htm	EX-10.3	10633
6	EXHIBIT 10.4	ex_262344.htm	EX-10.4	104640
7	EXHIBIT 10.5	ex_262345.htm	EX-10.5	61510
8	EXHIBIT 10.6	ex_262096.htm	EX-10.6	154290
9	EXHIBIT 10.7	ex_262097.htm	EX-10.7	12510
10	EXHIBIT 10.8	ex_262346.htm	EX-10.8	9145
11	EXHIBIT 99.1	ex_268327.htm	EX-99.1	14783
12		logo.jpg	GRAPHIC	10381
	Complete submission text file	0001437749-21-017701.txt		636799

Mailing Address 73 HIGH STREET BUFFALO NY 14203

Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810

CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)